Regional cerebral metabolic alterations in dementia of the Alzheimer type: positron emission tomography with [18F]fluorodeoxyglucose

J Comput Assist Tomogr. 1983 Aug;7(4):590-8. doi: 10.1097/00004728-198308000-00003.


Alzheimer disease is the most common cause of dementia in adults. Despite recent advances in our understanding of its anatomy and chemistry, we remain largely ignorant of its pathogenesis, physiology, diagnosis, and treatment. Dynamic positron emission tomography using [18F]fluorodeoxyglucose (FDG) was performed on the Donner 280-crystal ring in 10 subjects with dementia of the Alzheimer type and six healthy age-matched controls. Ratios comparing mean counts per resolution element in frontal, temporoparietal, and entire cortex regions in brain sections 10 mm thick obtained 40-70 min following FDG injection showed relatively less FDG uptake in the temporoparietal cortex bilaterally in all the Alzheimer subjects (p less than 0.01). Left-right alterations were less prominent than the anteroposterior changes. This diminished uptake was due to lowered rates of FDG use and suggests that the metabolic effects of Alzheimer disease are most concentrated in the temporoparietal cortex. Positron emission tomography is a most powerful tool for the noninvasive in vivo assessment of cerebral pathophysiology in dementia.

Publication types

  • Research Support, U.S. Gov't, Non-P.H.S.

MeSH terms

  • Aged
  • Alzheimer Disease / diagnostic imaging*
  • Alzheimer Disease / metabolism
  • Cerebral Cortex / metabolism
  • Dementia / diagnostic imaging*
  • Deoxy Sugars*
  • Deoxyglucose* / analogs & derivatives
  • Female
  • Fluorine*
  • Fluorodeoxyglucose F18
  • Humans
  • Male
  • Middle Aged
  • Radioisotopes*
  • Tomography, Emission-Computed*


  • Deoxy Sugars
  • Radioisotopes
  • Fluorodeoxyglucose F18
  • Fluorine
  • Deoxyglucose